About Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd is a company based in Hyderabad (India). The company has 98 employees. Oxygenta Pharmaceutical Ltd offers products and services including Drugs and Organic Fine Chemicals.
- Headquarter Hyderabad, India
- Employees 98
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Legal Name Oxygenta Pharmaceutical Limited
- Annual Revenue₹31.01 Cr
FY 2023 · -49% YoY
- Net Loss-₹11.57 Cr
FY 2023 · -37% margin
- EBITDA-₹7.12 Cr
FY 2023 · -23% margin
- Employee Count98
Associated legal entities of Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd operates through Oxygenta Pharmaceutical Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Oxygenta Pharmaceutical Limited Listed CIN L24110TG1990PLC012038 | Active | 27 Nov 1990 | Medak, Telangana | ₹31.0 Cr | 98 | 10 | View details |
Products & Services of Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd offers a comprehensive portfolio of products and services, including Drugs and Organic Fine Chemicals.
Drugs and pharmaceutical preparations are manufactured for various healthcare applications
Organic fine chemicals are produced for industrial and research purposes
Board of directors of Oxygenta Pharmaceutical Limited (Oxygenta Pharmaceutical Ltd)
Oxygenta Pharmaceutical Limited is the primary company behind Oxygenta Pharmaceutical Ltd. The board of Oxygenta Pharmaceutical Limited currently have 8 directors; the longest-serving is Vedavathi Gangavaram, appointed in 2025. 41 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vedavathi Gangavaram DIN 02870966 | Director | 20 Jun 2025 | 1 yr 3 mo | Oxygenta Pharmaceutical Limited |
| Veera Reddy Arava DIN 10832178 | Director | 20 Jun 2025 | 1 yr 3 mo | Oxygenta Pharmaceutical Limited |
| Sidda Reddy Kanuparthi DIN 07156289 | Director | 20 Jun 2025 | 1 yr 3 mo | Oxygenta Pharmaceutical Limited |
| Sharvari Swapnil Shinde DIN 11149764 | Director | 20 Jun 2025 | 1 yr 3 mo | Oxygenta Pharmaceutical Limited |
| Chandra Mouliswar Reddy Gangavaram DIN 00046845 | Whole-time director | 20 Jun 2025 | 1 yr 3 mo | Oxygenta Pharmaceutical Limited |
| Balasubba Reddy Mamilla DIN 01998852 | Whole-time director | 20 Jun 2025 | 1 yr 3 mo | Oxygenta Pharmaceutical Limited |
| Janardhana Reddy Yeddula DIN 03207357 | Additional Director | 23 May 2026 | 4 mo | Oxygenta Pharmaceutical Limited |
| Amireddy Venkatesu Reddy DIN 11087687 | Additional Director | 23 May 2026 | 4 mo | Oxygenta Pharmaceutical Limited |
IPO & Listings of Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd is a publicly listed company on the BSE with ticker symbol OXYGENTAPH in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onBSE: OXYGENTAPH
- Listed entityOxygenta Pharmaceutical Limited
- Exchange sectorHealth technology
- ISININE102E01018
- Share price₹48.60 (+1.91% on the day) · 2026-10-09
- Market capitalisation₹176 Cr
- EPS (diluted, trailing year)₹-3.67
- Volume (last session)3,568
Financials of Oxygenta Pharmaceutical Ltd
Figures of Oxygenta Pharmaceutical Limited, the primary company behind Oxygenta Pharmaceutical Ltd, for FY 2023. Revenue was ₹31.01 Cr (-49% year on year). Net loss was -₹11.57 Cr (-37% margin). EBITDA was -₹7.12 Cr (-23% margin). Revenue has grown at a compounded annual rate of +31% over three years and +17% over five years.
- ₹31.01 CrRevenue · FY 2023 · -49% YoY
- -₹11.57 CrNet loss · -37% margin
- -₹7.12 CrEBITDA · -23% margin
- ₹36.98 CrPaid-up capital
- 98Employees (provident fund records)
- +31%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹113 Cr | -₹17.6 Cr | -₹15.3 Cr |
| 2024 | ₹109 Cr | -₹10.3 Cr | -₹9.9 Cr |
| 2023 | ₹39.6 Cr | -₹3.5 Cr | -₹9.7 Cr |
| 2022 | ₹31.0 Cr | -₹11.6 Cr | -₹7.1 Cr |
| 2021 | ₹60.5 Cr | -₹0.6 Cr | ₹1.5 Cr |
Balance sheet, profit and loss, cash flow and ratios of Oxygenta Pharmaceutical Limited are on its company page.
Detailed financial statements for Oxygenta Pharmaceutical Ltd
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Latest news on Oxygenta Pharmaceutical Ltd
Complete news archive for Oxygenta Pharmaceutical Ltd
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Oxygenta Pharmaceutical Ltd
10 companies that operate in the same segment as Oxygenta Pharmaceutical Ltd (Chemicals Research & Training Services), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Application-oriented research is conducted in bioeconomy, AI, and climate technologies. | 1949 | Darmstadt, Hesse, Germany | USD 23.27 M | – | – | |
Developer of biotechnology-based solutions for sustainable agriculture and industrial applications. This company develops and implements technologi... | 2011 | Singapore, Singapore | USD 77 M | – | – | |
Research organization focused on cellular and molecular biology in India. | 1977 | Hyderabad, Telangana, India | – | – | – | |
Sustainable technology businesses are built and scaled globally. | 2001 | Woburn, Massachusetts, United States | USD 27 M | – | – | |
Clinical laboratory services are operated through a chain of facilities. | 1986 | Germany | – | – | – | |
Fluorochemicals research services are provided by Fluorok to clients. | 2022 | Kidlington, Oxfordshire, United Kingdom | USD 14.05 M | – | – | |
Laboratory testing services for pharmaceutical and packaging industries are provided. | 2014 | Hyderabad, Telangana, India | – | USD 7.07 M | 158 | |
Provider of materials functional polymers, structural composites, and environmental sensing research services | 2015 | Esch-sur-alzette, Luxembourg | – | – | – | |
Microbiological and chemical analyses are performed for research purposes. | 1989 | Gdynia, Pomeranian Voivodeship, Poland | USD 9.83 M | USD 587.65 K | – | |
Industrial enzymes are produced through advanced R&D infrastructure by LIVZYM. | 2014 | Istanbul, Turkey | USD 11 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Oxygenta Pharmaceutical Ltd has 98 employees.
The primary company behind Oxygenta Pharmaceutical Ltd, Oxygenta Pharmaceutical Limited, reported revenue of ₹31.01 Cr for FY 2023, down 49% year on year.
Oxygenta Pharmaceutical Limited, formerly known as S S Organics Limited, was incorporated in 1990 and converted to a public company in 1993, with a focus on the production of drugs and organic fine chemicals. Innovation is maintained through a significant workforce of researchers, while the company culture is shaped by values of integrity, imagination, and innovation. Research and development efforts emphasize speed and trust to create value, as operations are conducted from key locations in Telangana, India. The companys strategy integrates these elements to support ongoing manufacturing activities.
Oxygenta Pharmaceutical Ltd offers Drugs and Organic Fine Chemicals.
Yes, Oxygenta Pharmaceutical Ltd is publicly traded on BSE under the ticker symbol OXYGENTAPH.
Oxygenta Pharmaceutical Ltd operates through Oxygenta Pharmaceutical Limited.
The legal entities of Oxygenta Pharmaceutical Ltd currently have 10 directors, including Vedavathi Gangavaram, Veera Reddy Arava, Sidda Reddy Kanuparthi and others.